| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Seed |
| Investing | United Kingdom • Canada • Australia • New Zealand |
| Investment Range | $29,860,000 - $29,860,000 |
Founded in 2001 and headquartered in London, United Kingdom, IP Group is a venture capital firm dedicated to creating value for shareholders and stakeholders alike by investing in and growing science and technology-based companies.
With a focus on the healthcare, life science, technology, clean tech and biotech sectors, they aim to turn world-leading scientific discoveries into market-leading businesses capable of addressing global challenges and improving lives. IP Group specializes in Seed investments, with both maximum and minimum investment amounts set at approximately 29.86 million GBP.
Their investment strategy is centered around identifying promising ventures with potential for significant societal impact and aligning with the UN’s Sustainable Development Goals, reflecting a commitment to not just financial performance, but also positive social and environmental influences.
They work closely with a network of partner universities and research institutions to identify and foster innovative ideas, translating groundbreaking science and technology into successful commercial enterprises. IP Group's portfolio aims to build a future enriched by advances in life sciences, deep tech, and clean tech, leveraging its expertise to support businesses working on curing and preventing disease, creating digital resilience, and addressing the global climate challenge.
Their cleantech platform, Kiko Ventures, epitomizes this direction by investing in scalable climate technology solutions. The firm’s impact is further evidenced by frequent updates about significant events such as portfolio company sales or breakthroughs, highlighting both financial gains and advancements in their sectors of focus.

